Marjanovic Sonja, Krapels Joachim, Sousa Sonia, Castle-Clarke Sophie, Horvath Veronika, Chataway Joanna
Rand Health Q. 2015 Nov 30;5(2):4.
The National Institute for Health Research (NIHR) Invention for Innovation (i4i) programme supports the development of innovative medical technologies for patient benefit. The i4i product development stream involves collaborative projects between at least two partners from academia, the NHS and industry. Medical technology innovators apply for funding for one to three years, through a peer review-based process that includes presentation to a selection panel. The funding and business advice provided by i4i support the development of early-stage innovations, generally at proof of concept and prototype stages. Since its inception the product development stream has identified and supported 170 projects, led by 146 principal investigators (PIs). RAND Europe evaluated the programme, with the aim of identifying its outputs and impacts and examining the factors influencing performance. The evaluation findings should help inform the future of the programme. The evaluation used a multi-method approach, including a focused review of background information from i4i, scoping interviews with key informants, a survey of programme participants and case studies of projects representing diverse technologies and health needs.
英国国家卫生研究院(NIHR)的创新发明(i4i)项目致力于支持创新医疗技术的研发,以造福患者。i4i的产品开发流程涉及来自学术界、英国国家医疗服务体系(NHS)和行业的至少两个合作伙伴之间的合作项目。医疗技术创新者通过基于同行评审的流程申请为期一至三年的资金,该流程包括向一个选拔小组进行展示。i4i提供的资金和商业建议支持早期创新的发展,通常处于概念验证和原型阶段。自项目启动以来,产品开发流程已识别并支持了170个项目,由146位首席研究员(PI)牵头。兰德欧洲公司对该项目进行了评估,旨在确定其产出和影响,并审视影响项目绩效的因素。评估结果应有助于为该项目的未来发展提供参考。评估采用了多方法途径,包括对i4i的背景信息进行重点审查、对关键信息提供者进行范围界定访谈、对项目参与者进行调查,以及对代表不同技术和健康需求的项目进行案例研究。